These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37586638)

  • 1. Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment.
    Kyriakidou M; Caballero-Puntiverio M; Andreasen JT; Thomsen M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110841. PubMed ID: 37586638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test.
    Caballero-Puntiverio M; Lerdrup LS; Grupe M; Larsen CW; Dietz AG; Andreasen JT
    Psychopharmacology (Berl); 2019 Jun; 236(6):1839-1851. PubMed ID: 30656365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex.
    Sun H; Cocker PJ; Zeeb FD; Winstanley CA
    Psychopharmacology (Berl); 2012 Jan; 219(2):285-301. PubMed ID: 21809008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat.
    Robinson ES; Eagle DM; Mar AC; Bari A; Banerjee G; Jiang X; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2008 Apr; 33(5):1028-37. PubMed ID: 17637611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Atxn7-overexpressing mice showed hyperactivity and impulsivity which were ameliorated by atomoxetine treatment: A possible animal model of the hyperactive-impulsive phenotype of ADHD.
    Dela Peña IJI; Botanas CJ; de la Peña JB; Custodio RJ; Dela Peña I; Ryoo ZY; Kim BN; Ryu JH; Kim HJ; Cheong JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jan; 88():311-319. PubMed ID: 30125623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of ADHD medications on impulsive action in the mouse 5-choice serial reaction time task.
    Fitzpatrick CM; Andreasen JT
    Eur J Pharmacol; 2019 Mar; 847():123-129. PubMed ID: 30690006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting effects of d-amphetamine and atomoxetine on measures of impulsive action and choice.
    Higgins GA; Brown M; MacMillan C; Silenieks LB; Thevarkunnel S
    Pharmacol Biochem Behav; 2021 Aug; 207():173220. PubMed ID: 34175329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation.
    Grassi G; Micheli L; Di Cesare Mannelli L; Compagno E; Righi L; Ghelardini C; Pallanti S
    J Psychiatr Res; 2016 Dec; 83():240-248. PubMed ID: 27665536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice.
    Sifeddine W; Ba-M'hamed S; Landry M; Bennis M
    Pharmacol Rep; 2023 Apr; 75(2):342-357. PubMed ID: 36787018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine's effect on impulsive action in adulthood.
    Silveira MM; Murch WS; Clark L; Winstanley CA
    Behav Pharmacol; 2016 Jun; 27(4):350-63. PubMed ID: 26650252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADHD medication and the inverted U-shaped curve: A pharmacological study in female mice performing the rodent Continuous Performance Test (rCPT).
    Caballero-Puntiverio M; Lerdrup LS; Arvastson L; Aznar S; Andreasen JT
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109823. PubMed ID: 31765714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in "Impulsive" SHR/NCrl and Wistar Rats.
    Dela Peña I; Dela Peña IJ; de la Peña JB; Kim HJ; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Behav Genet; 2017 Sep; 47(5):564-580. PubMed ID: 28744604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of Atomoxetine.
    Coppola M; Mondola R
    J Psychoactive Drugs; 2018; 50(4):361-366. PubMed ID: 29877779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waiting impulsivity: a distinctive feature of ADHD neuropsychology?
    Van Dessel J; Morsink S; Van der Oord S; Lemiere J; Moerkerke M; Grandelis M; Sonuga-Barke E; Danckaerts M
    Child Neuropsychol; 2019 Jan; 25(1):122-129. PubMed ID: 29490561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.
    Price MZ; Price RL
    CNS Drugs; 2023 Jul; 37(7):655-660. PubMed ID: 37430151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making.
    Broos N; Loonstra R; van Mourik Y; Schetters D; Schoffelmeer AN; Pattij T; De Vries TJ
    Addict Biol; 2015 Jul; 20(4):714-23. PubMed ID: 25056833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between impulsive choice and impulsive action: a cross-species translational study.
    Broos N; Schmaal L; Wiskerke J; Kostelijk L; Lam T; Stoop N; Weierink L; Ham J; de Geus EJ; Schoffelmeer AN; van den Brink W; Veltman DJ; de Vries TJ; Pattij T; Goudriaan AE
    PLoS One; 2012; 7(5):e36781. PubMed ID: 22574225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
    Kelsey DK; Sumner CR; Casat CD; Coury DL; Quintana H; Saylor KE; Sutton VK; Gonzales J; Malcolm SK; Schuh KJ; Allen AJ
    Pediatrics; 2004 Jul; 114(1):e1-8. PubMed ID: 15231966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.